Hepatic Impairment: Hepatic metabolism accounts for almost one hundred% of diclofenac sodium prolonged-release tablets elimination, so people with hepatic illness could demand decreased doses of diclofenac sodium prolonged-release tablets compared to individuals with ordinary hepatic function. A dosage adjustment may be warranted when diclofenac is administered with CYP2C9 inhibitors or https://alexandert580flr9.wikihearsay.com/user